T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.15% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 15.34% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
1826
DELISTED
Barnes Group Inc.
B
| $1.59M | ﹤0.01% |
38,107
+29
| +0.1% | +$1.38K |
|
1827
Vir Biotechnology
VIR
$1.52B
| $1.59M | ﹤0.01% |
36,519
-39,334
| -52% | -$1.7M |
|
1828
Fluor
FLR
$6.96B
| $1.58M | ﹤0.01% |
98,834
+6,525
| +7% | +$107K |
|
|
WWE
1829
DELISTED
World Wrestling Entertainment
WWE
| $1.56M | ﹤0.01% |
27,651
+232
| +0.8% | +$12.1K |
|
1830
Donnelley Financial Solutions
DFIN
$1.17B
| $1.55M | ﹤0.01% |
44,889
-1,979
| -4% | -$65.3K |
|
|
VG
1831
DELISTED
Vonage Holdings Corporation
VG
| $1.55M | ﹤0.01% |
96,013
-4,414
| -4% | -$64K |
|
1832
Group 1 Automotive
GPI
$3.17B
| $1.54M | ﹤0.01% |
8,197
-894
| -10% | -$152K |
|
1833
Xerox
XRX
$412M
| $1.53M | ﹤0.01% |
76,118
+10,874
| +17% | +$247K |
|
|
TWOU
1834
DELISTED
2U Inc
TWOU
| $1.53M | ﹤0.01% |
1,523
-2
| -0.1% | -$2.34K |
|
1835
BGC Group
BGC
$5.2B
| $1.53M | ﹤0.01% |
293,636
+60,100
| +26% | +$319K |
|
1836
Outfront Media
OUT
$5.29B
| $1.53M | ﹤0.01% |
61,694
-5,471
| -8% | -$129K |
|
1837
White Mountains Insurance
WTM
$5.06B
| $1.52M | ﹤0.01% |
1,426
+16
| +1% | +$17.9K |
|
|
RPT
1838
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $1.52M | ﹤0.01% |
119,296
+122
| +0.1% | +$1.55K |
|
1839
National Health Investors
NHI
$3.47B
| $1.52M | ﹤0.01% |
28,406
+1,192
| +4% | +$74.5K |
|
|
LUMO
1840
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $1.52M | ﹤0.01% |
159,595
| – | – |
|
1841
Independence Realty Trust
IRT
$3.96B
| $1.51M | ﹤0.01% |
74,286
-15,700
| -17% | -$312K |
|
|
ITCI
1842
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.51M | ﹤0.01% |
40,522
+4,279
| +12% | +$149K |
|
|
TMHC
1843
DELISTED
Taylor Morrison
TMHC
| $1.5M | ﹤0.01% |
58,322
-11,861
| -17% | -$314K |
|
1844
Granite Construction
GVA
$5.41B
| $1.5M | ﹤0.01% |
37,981
-6,700
| -15% | -$265K |
|
1845
LiveRamp
RAMP
$2.3B
| $1.5M | ﹤0.01% |
31,698
-1,157
| -4% | -$52.2K |
|
|
JNCE
1846
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $1.5M | ﹤0.01% |
201,494
+15,636
| +8% | +$96.9K |
|
1847
Columbia Sportswear
COLM
$2.88B
| $1.49M | ﹤0.01% |
15,515
-2,812
| -15% | -$284K |
|
1848
Enpro
NPO
$7.12B
| $1.48M | ﹤0.01% |
17,037
-731
| -4% | -$64.2K |
|
1849
World Kinect Corp
WKC
$1.89B
| $1.48M | ﹤0.01% |
44,132
-746
| -2% | -$23.9K |
|
1850
Q2 Holdings
QTWO
$4.13B
| $1.48M | ﹤0.01% |
18,499
-792
| -4% | -$72.6K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.